SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Pharmalabs - Quaterly Results

05 Aug 2024 Evaluate
The revenue for the June 2024 quarter is pegged at Rs. 3934.86 millions, about 9.87% up against Rs. 3581.44 millions recorded during the year-ago period.Net profit declined -1.02% to Rs. 471.44 millions from Rs. 476.32 millions.Operating profit for the quarter ended June 2024 rose to 857.68 millions as compared to 816.03 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 3934.86 3581.44 9.87 3934.86 3581.44 9.87 15021.30 15112.50 -0.60
Other Income 21.13 48.59 -56.51 21.13 48.59 -56.51 110.10 12.80 760.16
PBIDT 857.68 816.03 5.10 857.68 816.03 5.10 3571.60 3096.20 15.35
Interest 42.49 40.34 5.33 42.49 40.34 5.33 166.30 204.90 -18.84
PBDT 815.19 775.69 5.09 815.19 775.69 5.09 3405.30 2891.30 17.78
Depreciation 182.93 154.37 18.50 182.93 154.37 18.50 660.10 557.70 18.36
PBT 632.26 621.32 1.76 632.26 621.32 1.76 2745.20 2333.60 17.64
TAX 160.82 145.00 10.91 160.82 145.00 10.91 738.70 616.30 19.86
Deferred Tax 45.15 35.00 29.00 45.15 35.00 29.00 278.10 95.00 192.74
PAT 471.44 476.32 -1.02 471.44 476.32 -1.02 2006.50 1717.30 16.84
Equity 453.13 453.13 0.00 453.13 453.13 0.00 453.10 453.10 0.00
PBIDTM(%) 21.80 22.78 -4.34 21.80 22.78 -4.34 23.78 20.49 16.05

Aarti Pharmalabs Share Price

699.45 -3.10 (-0.44%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×